<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Biogen Inc. ( BIIB , Financial) announced on Thursday that it has entered into an agreement that will see Samsung BioLogics ( XKRX:207940 , Financial) acquire Biogen’s equity stake in the Samsung Bioepis joint venture for an aggregate consideration of up to $2.3 billion. The cash injection should help Biogen reach important research goals, such as the next phase in clinical trials for its controversial Alzheimer’s treamtent, Aduhelm.
...read full article on GuruFocus
